Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824102) titled 'Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders' on Sept. 11.
Study Type: Observational
Primary Sponsor: Martin Blomberg Jensen
Condition:
Osteoporosis
Hypercalcemia
Primary Hyperparathyroidism
Adrenal Gland Disease
Pituitary Disease
Thyroid Diseases
Recruitment Status: Recruiting
Date of First Enrollment: January 1, 2026
Target Sample Size: 20000
Countries of Recruitment:
Denmark
To know more, visit https://clinicaltrials.gov/study/NCT07824102
Disclaimer: Curated by HT Syndication....